Wang Xiaodong 4

4 · BeOne Medicines Ltd. · Filed Jun 12, 2025

Insider Transaction Report

Form 4

Period: 2025-06-10

BeOne Medicines Ltd.ONC

Wang Xiaodong

DirectorOther

Transactions

Award
Ordinary Shares
[F1]
2025-06-10+98,696→ 5,180,861 total
Exercise/Conversion
American Depositary Shares
[F5]
2025-06-10$6.50/sh+41,760$271,440→ 41,760 total
Sale
American Depositary Shares
[F5][F6][F7]
2025-06-10$261.20/sh−2,901$757,753→ 38,859 total
Sale
American Depositary Shares
[F5][F6][F8]
2025-06-10$262.20/sh−15,878$4,163,262→ 22,981 total
Sale
American Depositary Shares
[F5][F6][F9]
2025-06-10$263.17/sh−16,094$4,235,501→ 6,887 total
Sale
American Depositary Shares
[F5][F6][F10]
2025-06-10$264.08/sh−6,787$1,792,314→ 100 total
Sale
American Depositary Shares
[F5][F6]
2025-06-10$264.85/sh−100$26,485→ 0 total
Award
Share Option (Right to Buy)
[F11][F12]
2025-06-10+185,796→ 185,796 total
Exercise: $20.26Exp: 2035-06-09→ Ordinary Shares (185,796 underlying)
Exercise/Conversion
Share Option (Right to Buy)
[F13]
2025-06-10−542,880→ 7 total
Exercise: $0.50Exp: 2025-07-19→ Ordinary Shares (542,880 underlying)

Holdings

Ordinary Shares
[F2]
(indirect: See Footnote)
1,025,063
Ordinary Shares
[F3]
(indirect: See Footnote)
3,953,100
Ordinary Shares
[F4]
(indirect: See Footnote)
50

Footnotes (13)

[F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
[F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.66 to $264.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F11]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
[F12]These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
[F13]These securities vest over a five-year period as follows: 20% on July 19, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service.
[F2]These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
[F3]These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
[F4]These securities are held by the spouse of the Reporting Person.
[F5]Each American Depositary Share represents 13 Ordinary Shares.
[F6]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.66 to $261.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.66 to $262.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.66 to $263.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Signature

/s/ Qing Nian, as Attorney-in-Fact|2025-06-12

Documents

1 file

4
wk-form4_1749764371.xmlPrimary
FORM 4